2015 American Transplant Congress

Tuesday, May 5, 2015

2:39pm-2:51pm

Pregnancy Outcomes in Kidney Recipients With Longer Transplant to Conception Intervals

S. Constantinescu,^1,2 L. Coscia,² D. Armenti,² P. Axelrod,¹ M. Ghanta,¹ S. Rao,¹ M. Moritz.^2,3

Concurrent Session: Kidney: Pregnancy, Metabolic Complications, Malignancy  •  Room 119-B

2:39pm-2:51pm

The Impact of Acute Rejection on Liver Transplant Survival in the New Millennium

J. Levitsky,¹ S. Forney,² B. Gillespie,³ R. Merion,^2,3 A. Lok,³ G. Levy,⁴ L. Kulik,¹ M. Abecassis,¹ A. Shaked.⁵

Concurrent Session: Liver: Immunosuppression and Rejection  •  Room 120-ABC

2:51pm-3:03pm

A Non-Haematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents the Transplanted Islet Graft Damage

M. Watanabe,¹ T. Lundgren,¹ Y. Saito,¹ A. Cerami,² M. Brines,² C.-G. östenson,³ M. Kumagai-Braesch.¹

Concurrent Session: Islet Transplantation: Basic  •  Room 121-C

2:51pm-3:03pm

AAV-Mediated TIMP-1 Gene Therapy Ameliorates Hepatic Ischemia/Reperfusion Injury

S. Duarte, T. Fujii, G. Lipshutz, R. Busuttil, A. Coito.

Concurrent Session: Late Breaking  •  Terrace IV

2:51pm-3:03pm

Cardiac Troponin T (cTNT) in the Assessment of Kidney Transplant (KTx) Benefit and Risk

F. Cosio,¹ A. Grupper,¹ P. Dean,² H. Amer.¹

Concurrent Session: Kidney: Cardiovascular and Metabolic  •  Terrace I-III

2:51pm-3:03pm

Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients

J. Locke,¹ R. Reed,¹ S. Mehta,¹ C. Durand,² R. Mannon,¹ P. MacLennan,¹ B. Shelton,¹ M. Martin,¹ H. Qu,¹ R. Shewchuk,¹ D. Segev.²

Concurrent Session: Disparities in Donation and Transplant Outcomes  •  Room 115-C

2:51pm-3:03pm

Epstein Barr Virus Modulates Host Cell MicroRNA-194 to Promote IL-10 Production in B Cell Lymphomas

A. Harris-Arnold, S. Schaffert, O. Hatton, C. Esquivel, S. Krams, O. Martinez.

Concurrent Session: PTLD and Other Malignancies  •  Room 122-AB

2:51pm-3:03pm

Impact of Pretransplant Sarcopenia and Sequential Changes in Sarcopenic Parameters After Living Donor Liver Transplantation

T. Kaido,¹ Y. Tamai,² K. Ogawa,¹ Y. Fujimoto,¹ A. Mori,¹ H. Okajima,¹ N. Inagaki,² S. Uemoto.¹

Concurrent Session: Liver: Living Donors and Partial Grafts  •  Room 115-AB

2:51pm-3:03pm

Morphometric Age as a Predictor of Survival Following Kidney Transplantation

M. Terjimanian,¹ D. Cron,¹ D. Cote,² J. Augustine,² K. Noon,² S. Wang,¹ M. Englesbe,¹ K. Woodside.²

Concurrent Session: Kidney: Pregnancy, Metabolic Complications, Malignancy  •  Room 119-B

2:51pm-3:03pm

Rabbit Antithymocyte Globulin Is Associated With Improved Patient and Graft Survival in Liver Transplantation. Experience With 595 Patients

M. Montenovo,¹ F. Jalikis,² L. Meng,³ Y. Matthew,² D. Andre,¹ H. Ryan,³ R. Jorge.¹

Concurrent Session: Liver: Immunosuppression and Rejection  •  Room 120-ABC